Chromosomal Mapping of Members of the cdc2 Family of Protein Kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk Inhibitor, p27Kip1 to Regions Involved in Human Cancer

Cancer Research

Volumn 55, Issue 6, 1995, Pages 1199-1205

  Bullrich, Florencia ^a   MacLachlan, Timothy K ^a   Sang, Nianli ^a   Druck, Teresa ^a   Veronese, Maria Luisa ^a   Heubner, Kay ^a   Croce, Carlo M ^a   Giordano, Antonio ^a   Allen, Steven L ^b   Chiorazzi, Nicholas ^b   Koff, Andrew ^c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; DNA; ENZYME INHIBITOR; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CHROMOSOME; CHROMOSOME MAP; CONTROLLED STUDY; HAMSTER; HETEROZYGOSITY; HUMAN; HUMAN CELL; HYBRID CELL; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

BASE SEQUENCE; CHROMOSOME MAPPING; CYCLINS; HUMAN; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN KINASES; PROTEIN P34CDC2; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028923566     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Moran, E. DNA tumor virus transforming proteins and the cell cycle. Review. Curr. Opin. Genes Dev., 3: 63–70, 1993.
2. Chittenden, P., Livingston, D. M., and Kaelin, W. G. The T/ElA-binding domain of the retinoblastoma gene product can interact selectively with a sequence-specific DNA binding protein. Cell, 65: 1073–1082, 1991.
3. Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., and Nevins, J. R. The E2F transcription factor is a cellular target for the RB protein. Cell, 65: 1053–1061, 1991.
4. Giordano, A., Whyte, P., Harlow, E., Franza, B. R., Jr., Beach, D., and Draetta, G. A 60 kD cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell, 58: 981–990, 1989.
5. Wang, J., Chenivesse, X., Henglein, B., and Brechot, C. Hepatitis B virus integration in a cyclin A gene in hepatocellular carcinoma. Nature (Lond.), 343: 555–557, 1990.
6. Giordano, A., McCall, C., Whyte, P., and Franza, B. R. Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus El A gene product. Oncogene, 6: 481–485, 1991.
7. Pines, J., and Hunter, T. Human cyclin A is adenovirus ElA-associated protein p60 and behaves differently from cyclin B. Nature (Lond.), 346: 760, 1990.
8. Giordano, A., Lee, J. H., Schepper, J. A., Herrmann, C., Harlow, E., Deuschle, U., Beach, D., and Franza, B. R., Jr. Cell cycle regulation of histone HI kinase activity associated with adenovirus protein E1A. Science (Washington DC), 253:1271–1275, 1991.
9. Booher, R., and Beach, D. Interaction between cdcl3 and cdc2 in the mitosis of fission yeast; dissociation of the Gl and G2 roles of the cdc2 protein kinase. EMBO J., 6: 3441–3447, 1987.
10. Nurse, P., and Bisset, Y. Gene required in Gl for commitment to cell cycle and in G2 for control of mitosis in fission yeast. Nature (Lond.), 292: 558–560, 1991.
11. Meyerson, M., Enders, G. H., Wu, C.-H., Su, L-K, Gorka, C., Nelson, C., Harlow, E., and Tsai, L.-H. A family of cdc2-related protein kinases. EMBO J., 11: 2209–2917,1992.
12. Bates, S., Bonetta, L., MacAllan, D., Parry, D., Holder, A., Dickson, C., and Peters, G. cdk6 (PLSTIRE) and cdk4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin Dl. Oncogene, 9: 71–79, 1993.
13. Pines, J. Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem. Sci., 18: 195–197, 1993
14. Rosenblatt, J., Gu, Y., and Morgan, D. O. Human cyclin-dependent kinase 2 is active during S and G2 of the cell cycle and associated with cyclin A. Proc. Natl. Acad. Sci. USA, 89: 2824–2828, 1992.
15. van den Heuvel, S., and Harlow, E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science (Washington DC), 262: 2050–2054, 1993.
16. Meyerson, M., and Harlow, E., Identification of Gl kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14: 2077–2086, 1994.
17. Motokura, T., and Arnold, A. Cyclin D and oncogenesis. Curr. Opin. Genes Dev., 3: 5–10, 1993.
18. Demetrick, D. J., Zhang, H., and Beach, D. H. Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes. Cytogenet. Cell Genet., 66:72–74, 1994.
19. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 358: 80–83, 1992.
20. Khatib, Z. A., Matsushime, H., Valentine, M., Shapiro, D. N., Sherr, C. J., and Look, A. T. Coamplification of the CDK4 gene with MDM2 and GU in human sarcomas. Cancer Res., 53: 5535–5541, 1993.
21. Grana, X., Claudio, P. P., De Luca, A., Sang, N., and Giordano, A. PISSLRE, a novel human cdc2-related protein kinase. Oncogene, 9: 2097–2103, 1994.
22. Brambilla, R., and Draetta, G. Molecular cloning of PISSLRE, a novel member of the cdk family of protein serine/threonine kinases. Oncogene, 9: 3037–3041, 1994.
23. Grana, X., DeLuca, A., Sang, N., Fu, Y., Claudio, P. P., Rosenblatt, J., Morgan, D. O., and Giordano, A., PITALRE, a nuclear cdc2-related protein kinase that phosphory-lates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. USA, 91: 3834–3838, 1994.
24. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49–53, 1991.
25. Mercer, E. W. Cell cycle regulation and the P53 tumor suppressor protein. Crit. Rev. Eukaryotic Gene Expression, 2: 251–263, 1992.
26. El-Deiry, W. S., Tokino, T., Velculesco, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817–825, 1993.
27. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., Beach, D., p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701–704, 1993.
28. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753–756, 1994.
29. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavitigan, S. V., Stockbert, E., Day, R. S., III, Johnson, B. E., and Skolnik, M. H., A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436–440, 1994.
30. Ohta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D., Mastrangelo, M., Singh, A. D., Shields, J. A., Shields, C. L., Croce, C. M., and Huebner, K. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in Melanoma. Cancer Res., 54: 5269–5272, 1994.
31. Polyack, K., Lee, M.-L., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J. Cloning of p27kipl, a cyclin dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59–66, 1994.
32. Toyishima, H., and Hunter, T. p27, a novel inhibitor of Gl cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 67–74, 1994.
33. Huebner, K., Druck, T., Croce, C. M., and Thiesen, H.-J. Twenty-seven nonoverlap-ping zinc finger cDNAs from human T cells map to nine different chromosomes with apparent clustering. Am. J. Hum. Genet., 48: 726–740, 1991.
34. Huebner, K., Druck, T., LaForgia, S., Lasota, J., Croce, C. M., Lanfrancone L., Donti, E., Pengue, G., LaMantia, G., Pellicci, P. G., and Lania, L. Chromosomal localization of four human ZNF cDNAs. Hum. Genet., 91: 217–223, 1993.
35. LaForgia, S.K., Morse, B., Levy, J., Barnea, G., Li, F., Cannizzaro, L. A., Nowell, P. C., Glick, J., Boghosian-Sell, L. Weston, A., Harris, C. C., DrabKin, H., Petterson, D., Croce, C. M., Patterson, D., Schlessinger, J., and Huebner, K. Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc. Natl. Acad. Sci. USA, 81: 5036–5040, 1991.
36. Tsai, L.-H., Harlow, E., and Meyerson, M. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus ElA-associated p33 kinase. Nature (Lond.), 353: 174–177, 1991.
37. Xiong, Y., Zhang, H., and Beach, D. D type cyclins associated with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71: 504–514, 1992.
38. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavitigian, S., Liu, Q., Cochran, C., Bennet, L. M., Ding, W., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66–71, 1994.
39. Cropp, C. S., Champeme, M. H., Liderau, R., and Callahan, R. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res., 53: 5617–5619, 1993.
40. Juliusson, G., and Gharton, G. Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenic and clinical implications. Cancer Genet. Cytogenet., 45: 143–160, 1990.
41. Fletcher, J. A., Gibas, Z., Donovan, K., Perez-Atayde, A., Genest, D., Morton, C. C., and Lage, J. M. Ovarian granulosa-stroma cell tumors are characterized by trisomy 12. Am. J. Pathol., 138: 515–520, 1991.
42. Schichman, S. A., Caligiuri, M. A., Gu, Y., Strout, M. P., Canaani, E., Bloomfield, C. D., and Croce, C. M. ALL-1 partial duplication in acute leukemia. Proc. Natl. Acad. Sci. USA, 91: 6236–6239, 1994.
43. Showe, L. C., and Croce, C. M. The role of chromosomal translocations in B- and T-cell neoplasia. Annu. Rev. Immunol., 5: 253–211, 1987.
44. Shtivelman, E., Lifshitz, B., Gale, R. P., and Canaani, E. Fused transcript for abl and bcr genes in chronic myelogenous leukemia. Nature (Lond.), 315: 550–554, 1985.
45. Sawyers, C. L., and Denny, C. T. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell, 77: 171–173, 1994.
46. Weinberg, R. A. The retinoblastoma gene and gene product. Cancer Surv., 12:43–57, 1992.
47. Futreal, P. A., Cochran, C., Marks, J. R., Iglehart, J. D., Zimmerman W., Barret, J. C., and Wiseman, R. W. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line. Cancer Res., 54: 1791–1794, 1994.
48. Jonveaux, P., Le Coniat, M., Derre, J., Vecchione, D., and Berger, R. Deletion of (7pl3–14) in non-Hodgkin's lymphoma. Cancer Genet. Cytogenet., 50:53–56,1990.
49. Offit, K., Parza, N. Z., Jhanwar, S. C., Filippa, D., Wachtel, M., and Chagenti, R. S. Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma. Genes Chromosomes Cancer, 7: 1–7, 1993.
50. Mitelman, F., Kaneko, Y., and Berger, R. Report of the Committee on Chromosome Changes in Neoplasia, Chromosome Coordinating Meeting (1992). In: A. J. Cutic-chia, P. L. Pearson, and H. P. Klinger (eds.), Genome Priority Reports, Vol. 1, pp. 700–726. Basel: S. Karger AG, 1993.
51. Orlow, I., Lianes, P., Lacombe, L., Dalbagni, G., Reuter, V. E., and Cordon-Cardo, C. Chromosome 9 alleleic losses and microsatellite alterations in human bladder tumors. Cancer Res., 54: 2848–2851, 1994.
52. Pietenpol, J. A., Bohlander, S. K., Sato, Y., Papadopoulos, N., Liu, B., Friedman, C.,Trask, B. J., Roberts, J. M., Kinzler, K. W., Rowley, J. D., and Vogelstein, B. Assignment of the p27Kipl gene to 12pl3 and its analysis in leukemias. Cancer Res., 55: 1206–1210, 1995.
53. Ponce-Castaneda, M. V., Lee, M.-H., Latres, E., Polyak, K., Lacombe, L., Montgomery, K., Mathew, S., Krauter, K., Sheinfeld, J., Massague, J., and Cordon-Cardo, C. p27Kipl: Chromosomal mapping to 12pl2 and absence of mutations in human tumors. Cancer Res., 55: 1211–1214, 1995.
54. Watanabe, T., Hotta, T., Ichikawa, A., Kinoshita, T., Nagai, H., Uchida, T., Murate, T., and Saito, H. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood, 84: 3158–3165, 1994.
55. Rodriguez, E., Houldsworth, J., Reuter, V. E., Meltzer, P., Zhang, J., Trent, J. M., Bosl, G. J., and Chaganti, R. S. Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes Cancer, 8: 230–236, 1993.
56. Tsuda, H., Callen, D. F., Fukutomi, T., Nakamura, Y., and Hirohashi, S. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res., 54: 513–517, 1994.
57. Bergerheim, U. S. R., Kunimi, K., Collins, V. P., and Ekman, P. Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes Chromosomes Cancer, 3: 215–220, 1991/